DalsnaFinance › Analyst accuracy › Citi › MRNA target
Moderna Sinks 6% on Citi Downgrade; Merck and Pfizer Stay Flat - 24/7 Wall St.
Citi analyst Geoff Meacham lowered Moderna to Sell from Hold while raising the price target to $80 from $60
A fact about what Citi published, as reported by 247wallst.com, not a recommendation from Dalsna Finance; Citi is not affiliated with this site.
Full methodology: how targets are collected, scored, ranked and corrected, what each field means, and how to cite the data.